IRF5 and thyroid gland carcinoma: On the contrary, IRF5 stimulated thyroid cancer proliferation (Figure 3B, C), protected malignant thyroid cells from the cytotoxic effects of different antiblastic compounds (Figure 4), and significantly increased their colony-forming ability (Figure 5B).